(Q46099117)
Statements
1 reference
A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia (English)
1 reference
Bruce J Kinon
1 reference
Lu Zhang
1 reference
Brian A Millen
1 reference
Olawale O Osuntokun
1 reference
Judy E Williams
1 reference
Sara Kollack-Walker
1 reference
Kimberley Jackson
1 reference
Ludmila Kryzhanovskaya
1 reference
Natalia Jarkova
1 reference
HBBI Study Group
1 reference
1 June 2011
1 reference
31
1 reference
3
1 reference
349-355
1 reference